Carroll C L, Goodman D M, Superina R A, Whitington P F, Alonso E M
Department of Pediatrics, Children's Memorial Hospital and Northwestern University Medical School, Chicago, IL, USA.
Pediatr Transplant. 2003 Aug;7(4):289-95. doi: 10.1034/j.1399-3046.2003.00084.x.
More reliable methods are needed to identify children at risk for poor outcomes following liver transplantation. The Pediatric Risk of Mortality (PRISM) Score is a physiology-based scoring system used to quantify risk of mortality in pediatric intensive care unit (ICU) populations. We evaluated the PRISM Score as a predictor of outcomes including survival in the pediatric liver transplant (LT) population. We retrospectively reviewed the records of 67 consecutive LTs performed between August 1997 and February 2000 at an urban, tertiary children's hospital in Chicago, IL, USA. Four PRISM Scores were calculated to determine which periods were most meaningful. A Classic PRISM Score was calculated during first 24 h of ICU admission, and three PRISM Scores were timed with the patient's transplant: a pre-LT PRISM Score (24 h prior to transplant whether in ICU or not), a 24-h post-LT PRISM Score and a 48-h post-LT PRISM Score. These PRISM Scores and other predictors including transplant number, UNOS status and PELD Score were compared with outcomes including survival using univariate methods. The pre-LT, the 24- and the 48-h PRISM Score were associated with the post-LT number of ventilated days (p < 0.05), ICU days (p < 0.05) and with 1-yr survival (p < 0.04). The PRISM Scores were not related to the post-LT hospital length of stay (LOS) or to 1-yr re-transplantation. The PELD Score correlated with the post-LT hospital LOS, but was not associated with mortality or with the ICU LOS. A patient's UNOS status and Classic PRISM Score were not associated with any of the outcomes measured. PRISM Scores are valid predictors of outcome including survival in pediatric LT recipients. These findings help to demonstrate the importance in this population of a patient's general physiologic condition and its influence on the overall hospital course and survival.
需要更可靠的方法来识别肝移植后预后不良风险的儿童。儿科死亡风险(PRISM)评分是一种基于生理学的评分系统,用于量化儿科重症监护病房(ICU)人群的死亡风险。我们评估了PRISM评分作为包括儿科肝移植(LT)人群生存率在内的预后预测指标。我们回顾性分析了1997年8月至2000年2月在美国伊利诺伊州芝加哥市一家城市三级儿童医院连续进行的67例肝移植记录。计算了四个PRISM评分以确定哪些时间段最有意义。在ICU入院的最初24小时内计算经典PRISM评分,并且三个PRISM评分与患者的移植时间同步:移植前PRISM评分(移植前24小时,无论是否在ICU)、移植后24小时PRISM评分和移植后48小时PRISM评分。使用单变量方法将这些PRISM评分和其他预测指标(包括移植次数、UNOS状态和PELD评分)与包括生存率在内的预后进行比较。移植前、移植后24小时和48小时的PRISM评分与移植后通气天数(p<0.05)、ICU住院天数(p<0.05)以及1年生存率(p<0.04)相关。PRISM评分与移植后住院时间(LOS)或1年再次移植无关。PELD评分与移植后住院LOS相关,但与死亡率或ICU住院LOS无关。患者的UNOS状态和经典PRISM评分与所测量的任何预后均无关。PRISM评分是儿科肝移植受者包括生存率在内的预后有效预测指标。这些发现有助于证明该人群中患者一般生理状况的重要性及其对整体住院过程和生存率的影响。